According to BioNexus Gene Lab's latest financial reports and stock price the company's current number of shares outstanding is 11,228,753. At the end of 2023 the company had 11,228,753 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 11.22 M | -22.08% |
2022 | 14.4 M | 0.99% |
2021 | 14.26 M | 66.67% |
2020 | 8.56 M | 0% |
2019 | 8.56 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 57,402,226 | 411.21% | ๐บ๐ธ USA |